Abstract
Background The lack of adequate resources in international cooperation limits the study of anatomopathological specimens. The literature on potentially inexpensive and available fixation media is scarce.
Material and methods Our surgical team prospectively collected specimens during cooperation campaigns developed in Senegal. Lesions were fixed in parallel in 10% formalin (FF) and 70% ethyl alcohol (AF). Hematoxylin and eosin sections (HE) and immunohistochemistry (IHC) techniques were performed. Images were anonymized and assessed by two senior and two junior pathologists, who evaluated the quality of staining and diagnostic feasibility using an anonymized questionnaire.
Results Three surgical specimens were included: 1 lymph node (3 HE, 4 IHC), one seborrheic keratosis (2 HE, 5 IHC), and one branchial remnant (2 HE, 2 IHC). Fixation times were similar in all the specimens (10-13 days). All FF HE were diagnostic. AF H&E was 100% diagnostic in the 5/7 sections and 75% in the remaining sections. In most cases, pathologists preferred FF. CK7, P40, EMA, CKAE1/AE3, and TTF1 were 100% diagnostic in both groups. CD20, CD45, and EMA were 100% diagnostic (FF) and 75% diagnostic (AF). CD10 was 75% diagnostic (FF) and 25% diagnostic (AF). BCL6 was 75% diagnostic (FF) and 100% diagnostic (AF). IHC preferences were inconsistent.
Conclusions 70% ethyl alcohol has a worse fixation profile than 10% formalin but allows diagnosis in most cases. The immunoreactivity observed is variable depending on the tissue and the stain used. Based on these findings, it can be considered an inexpensive, readily available, and potentially helpful fixation medium for diagnosis in developing countries where surgical cooperation campaigns are conducted. Nevertheless, future studies of larger sample sizes and characterizing other histologic subtypes are needed to confirm these findings.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study has not received external funding. None of the authors have financial disclosures to declare.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The institutional review board (IRB) from Complejo Asistencial Universitario de León approved this study under code 24026. The ethical principles of the Declaration of Helsinki (2013) were followed.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Funding This study has not received external funding. None of the authors have financial disclosures to declare.
Conflicts of interest No financial or non-financial benefits have been received or will be received from any party related directly or indirectly to the subject of this article.
Data availability All data on this study are available upon justified request through the author in correspondence.
Ethical approval The institutional review board (IRB) from Complejo Asistencial Universitario de León approved this study under code 24026. The ethical principles of the Declaration of Helsinki (2013) were followed.
Consent for publication All patients or their legal representatives signed an informed consent form before being included in the study. Following current international legislation, all patient data was anonymized.
Data Availability
All data on this study are available upon justified request through the author in correspondence.
